Table 6. Effects of various laboratory and clinical factors to rebounding PDMPs level in 17 patients with KD in the convalescent phase.
| Factors | B | OR (95% CI) | P |
|---|---|---|---|
| Platelet | 0.000 | 1.000 (1.000–1.000) | 0.210 |
| NT-proBNP | −0.001 | 0.999 (0.997–1.000) | 0.040 |
| CRP | 0.422 | 1.525 (1.047–2.221) | 0.028 |
| Albumin | −0.448 | 0.639 (0.107–23.934) | 0.809 |
| Period of low dose ASA Tx | 0.023 | 1.024 (0.912–1.150) | 0.693 |
| CAL | 0.130 | 1.139 (0.107–1.150) | 0.914 |
PDMP = platelet-derived microparticle, KD = Kawasaki disease, B = nonstandard coefficient, OR = odds ratio, CI = confidence interval, NT-proBNP = N-terminal pro-brain natriuretic peptide, CRP = C-reactive protein, ASA = acetylsalicylic acid, Tx = treatment, CAL = coronary artery lesion.